Stroke-preventing technology demonstrated in JoVE

The WATCHMAN device is inserted into a small cavity in the heart to prevent clots from traveling to the brain. Credit: © Journal of Visualized Experiments

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.

Researchers from Atritech, now part of Boston Scientific, developed the WATCHMAN device, a small mesh umbrella that can be inserted into part of the heart cavity to prevent the formation of that cause strokes.

Currently, the anti-coagulant is used to prevent strokes, but the drug comes with other risks.

" has a lot of side-effects. One major side-effect is the bleeding risk," said paper author Dr. Sven Mobius-Winkler. "Therefore, only 50 percent of the patients who should take Warfarin actually take it."

The WATCHMAN device gives patients another option. It has already been approved for use in the European Union and Australia, and secured investigational approval from the FDA in 2009.

To help train doctors how to use the device, doctors from the University of Leipzig Heart Center in Germany are publishing the full WATCHMAN placement procedure in the Journal of Visualized Experiments (JoVE), the world's first and only peer-reviewed, PubMed indexed, science and medicine video journal.

"Intervention and closure of the left atrial appendage is a complex procedure," said Dr. Mobius- Winkler. "For inexperienced physicians, it is hard to learn this procedure and therefore the video can help by doing step-by-step the implantation."

"The WATCHMAN device will give patients with atrial fibrillation another option rather than anti-coagulant drugs," said JoVE Editor Dr. Robert Dolan. "This article demonstrates the implantation of the device and will help clinicians gain expertise with the procedure, helping many of the patients who are unable or unwilling to take warfarin."

More information: The procedure will be published in JoVE on Feb. 28, and can be seen here: http:// www.jove.com/video/3671/the-wa… r-atrialfibrillation

add to favorites email to friend print save as pdf

Related Stories

Study finds warfarin underutilized in women

Dec 13, 2011

Dr. Rabab Mohsin, an internal medicine resident at the University of Kentucky, working with Dr. Alison Bailey of the University of Kentucky Gill Heart Institute, has discovered that the drug warfarin was underutilized in ...

Study: Plavix plus aspirin helps prevent strokes

Mar 31, 2009

(AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.

Recommended for you

Use of drug-eluting stents may cut in-hospital mortality

Nov 20, 2014

(HealthDay)—Use of drug-eluting stents (DES) rather than bare-metal stents (BMS) for percutaneous coronary intervention (PCI) is associated with lower rates of in-hospital mortality, according to research ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.